Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-782-3 | CAS number: 6731-36-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental Starting Date: 28-Jul-2010, Experimental CCCCompletion Date: 11-Aug-2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological defiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide
- EC Number:
- 229-782-3
- EC Name:
- Di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide
- Cas Number:
- 6731-36-8
- Molecular formula:
- C17H34O4
- IUPAC Name:
- 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane
- Details on test material:
- Identification: di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide
Batch Number: 0905137109
CAS Number: 6731-36-8
Description: colorless liquid
Purity: 98.16%
Expiry (Retest) Date: 01-Jun-2011
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories Ltd, Kreuzelweg 53, 5961 NM Horst / Netherlands
- Age at study initiation: 10 weeks
- Weight at study initiation: Males: 290.1 to 295.4 g, females: 191.1 to 192.7 g
- Fasting period before study: none
- Housing: Animals were housed in groups of 3 of the same sex in Makrolon® type-IV cages with wire mesh tops and standard softwood bedding ("Lignocel" J. Rettenmaier & Söhne GmbH & Co KG, 73494 Rosenberg / Germany, imported by Provimi Kliba AG, 4303 Kaiseraugst / Switzerland) including paper enrichment (Enviro-dri from Lillico, Biotechnology, Surrey, UK)
- Diet (e.g. ad libitum): Animals had ad libitum access to a pelleted standard Harlan Teklad 2914C rat maintenance diet (Provimi Kliba AG, 4303 Kaiseraugst, Switzerland) batch no. 20/10 except during the period when the animals were restrained in exposure tubes.
- Water (e.g. ad libitum): Community tap water from Füllinsdorf ad libitum in water bottles, except during the period when they were restrained in exposure tubes.
- Acclimation period: for 13 days under laboratory conditions, after a clinical health examination
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12/12
Animal Welfare: This study was performed in an AAALAC-accredited laboratory in accordance with the Swiss Animal Protection Law under license no. 397
IN-LIFE DATES: From: To: 28-Jul-2010 to 11-Aug-2010
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: The test atmosphere was generated using a Hospitak N°950 nebulizer connected to a syringe pump. The polyethylene injector inside the nebulizer was replaced by a stainless steel injector
- Exposure chamber volume: not applicable
- Method of holding animals in test chamber: The animals were confined separately in restraint tubes which were positioned radially around the exposure chamber.
- Source and rate of air: compressed air was supplied by means of an oil free compressor and passed respiratory quality filters before it was introduced into the exposure system
- Method of conditioning air: respiratory quality filters
- System of generating particulates/aerosols: The test atmosphere was generated using a Hospitak N°950 nebulizer connected to a syringe pump. The polyethylene injector inside the nebulizer was replaced by a stainless steel injector
- Method of particle size determination: Mercer impactor
- Treatment of exhaust air: filtered
- Temperature, humidity, pressure in air chamber: 22.8 °C, 3.5 % rel. humidity, 20.4 % oxygen
TEST ATMOSPHERE
- Brief description of analytical method used: Gravimetric determinations of aerosol concentration were performed four times during exposure. The samples were collected on a Millipore®durapore filter, Type HVLP loaded in a 47 mm in-line stainless steel filter sampling device. The filters were weighed before and immediately after sampling using a calibrated balance. The test aerosol concentration was calculated from the amount of test item present on the filter and the sample volume.
Chemical determinations of aerosol concentration were performed four times during exposure. The samples were collected on a Millipore®durapore filter, Type HVLP loaded in a 47 mm in-line stainless steel filter sampling device. The filters were transferred into appropriate labeled vials containing 5 mL of Acetonitrile, forwarded on dry ice to the scientist responsible for formulation analysis and stored at -20 ± 5 °C until analysis. The samples were analyzed using a GC method provided by the Sponsor and implemented at Harlan Laboratories Ltd.
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle (if applicable): no vehicle used
- Concentration of test material in vehicle (if applicable):
- Justification of choice of vehicle:
- Lot/batch no. (if required):
- Purity:
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution:
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): MMAD: 1.98/2.17/2.10 µm, GSD: 1.96/1.97/2.08
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4
- Concentrations:
- gravimetric: 5.3 mg/L air
chemical: 5.6 mg/L air
nominal: 6.1 mg/L air - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations for viability were recorded once before exposure on the day of exposure (test day 1), three times during exposure, immediately and 1 h after exposure on test day 1 and twice daily during the observation period. Each animal was examined three times during exposure, immediately and 1 h after exposure on test day 1 and once daily during the observation period. Observations were detailed and carefully recorded using explicitly defined scales as appropriate. Only grossly abnormal signs were detectable during exposure as the animals were restrained in the exposure tubes. The body weight of each animal was recorded on test days 1 (before exposure), 2, 4, 8 and 15 (before necropsy).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- no
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.6 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- none
- Clinical signs:
- other: (See Individual Tables in attachement) Salivation was observed during and immediately after exposure in all animals. Decreased activity, hunched posture, bradypnea and ruffled fur were recorded in all animals after the end of exposure on day 1. Ruffled f
- Body weight:
- (See Individual Tables in attachement).
From test day 1 to test day 2, slight body weight loss was noted in all animals. Thereafter normal body weight development was recorded. - Gross pathology:
- (See Individual Tables in attachement).
There were no macroscopic findings. - Other findings:
- none
Any other information on results incl. tables
Test Atmosphere Conditions
Temperature, relative humidity and oxygen concentration during exposure were considered to be satisfactory for this type of study.
Data on temperature, relative humidity and oxygen concentration are presented in the following table:
Recording Time [hours:min] |
O2Concentration [Vol %] |
Temperature [°C] |
Relative Humidity [% RH] |
07:30 |
20.3 |
22.7 |
7.6 |
08:00 |
20.4 |
22.8 |
5.8 |
08:30 |
20.4 |
22.9 |
2.3 |
09:00 |
20.4 |
22.9 |
2.2 |
09:30 |
20.4 |
22.8 |
2.2 |
10:00 |
20.3 |
22.8 |
4.1 |
10:30 |
20.4 |
22.8 |
2.4 |
11:00 |
20.4 |
22.8 |
2.4 |
11:30 |
20.4 |
22.8 |
2.2 |
Mean |
20.4 |
22.8 |
3.5 |
St. Dev. |
0.0 |
0.0 |
2.0 |
N |
9 |
9 |
9 |
Determination of Nominal Aerosol Concentration
The nominal aerosol concentration was 6.1 mg/L air.
Gravimetric Determination of Aerosol Concentrations
The mean gravimetric aerosol concentration determined was 5.3 mg/L air as targeted. The aerosol concentration was stable during the exposure period. Data on gravimetric aerosol concentrations are presented in the following table:
Sampling Time [hours:min] |
Sampling Volume [L] |
Amount of Test Item on the Filter [mg] |
Gravimetric Aerosol Concentration [mg/L air] |
8:00 – 08:04 |
4.0 |
20.847 |
5.5 |
9:00 – 09:03 |
3.0 |
14.620 |
5.1 |
10:00 – 10:03 |
3.0 |
14.978 |
5.2 |
11:00 – 11:03 |
3.0 |
15.404 |
5.4 |
Mean |
|
|
5.3 |
St. Dev. |
|
|
0.2 |
N |
|
|
4 |
Chemical Determination of Aerosol Concentrations
The mean chemical aerosol concentration determined was 5.6 mg/L air as targeted. The aerosol concentration was stable during the exposure period. The chemical aerosol concentration compared favourably with the gravimetrically determined concentration. This was in accordance with the high purity of the test item. Details on chemically determined aerosol concentrations are presented in the following table:
Sampling Time [hours:min] |
Sampling Volume [L] |
Amount of Test Item on the Filter [mg] |
Chemical Aerosol Concentration [mg/L air] |
8:00 – 08:04 |
4.0 |
22.72 |
5.9 |
9:00 – 09:03 |
3.0 |
15.04 |
5.2 |
10:00 – 10:03 |
3.0 |
15.48 |
5.4 |
11:00 – 11:03 |
3.0 |
16.78 |
5.9 |
Mean |
|
|
5.6 |
St. Dev. |
|
|
0.3 |
N |
|
|
4 |
Particle Size Distribution:
The Mass Median Aerodynamic Diameters (MMAD) obtained from three gravimetric measurements of particle size distribution during the exposure were similar (MMAD between 1.98µmand 2.17µm). This led to the conclusion that the particle size of the generated aerosol was stable during the whole exposure period. The MMADs were well within the target range of 1 to 4mm, thus deposition of the particles can be assumed to have occurred in both the upper and the lower respiratory tract. In addition, the Geometric Standard Deviations (GSD) were within the target range of 1.5 to 3. Hence, the particle size distributions obtained were considered to be appropriate for acute inhalation toxicity testing.
Data on particle size distribution are presented in the following table:
Time |
Total Amount Collected |
Percentages: |
MMAD |
GSD |
Corr. Coeff. |
% < |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
||||||
08:01 |
947 |
9.3 |
17.3 |
17.4 |
21.1 |
22.1 |
10.6 |
0.1 |
2.1 |
1.98 |
1.96 |
0.965 |
85.3% |
09:45 |
954 |
11.2 |
18.0 |
22.3 |
23.5 |
16.1 |
6.8 |
0.0 |
2.0 |
2.17 |
1.97 |
0.957 |
81.6% |
11:10 |
820 |
11.7 |
17.4 |
20.6 |
24.4 |
14.8 |
7.6 |
0.0 |
3.5 |
2.10 |
2.08 |
0.952 |
81.0% |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In conclusion, the LC50 of di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide obtained in this study was estimated to be greater than 5.6 mg/L air (chemically determined mean aerosol concentration). There was no indication of relevant sex-related differences in toxicity of the test item.
- Executive summary:
A group of three male and three female albino rats [RccHanTM:WIST(SPF)] was exposed by nose-only, flow-past inhalation for four hours to the test item at a chemically determined mean concentration of 5.6 mg/L air. All animals were observed for clinical signs and mortality during the inhalation exposure and the subsequent 14-day observation period. Body weights were recorded prior to exposure on test day 1, and during the observation period on test days 2, 4, 8 and 15 before necropsy. On test day 15 all animals were sacrificed and necropsied. The ranges of aerosol concentration, temperature, relative humidity, oxygen content and airflow rate measured during the exposure were considered to be satisfactory for a study of this type. In addition, the test item was considered to be respirable to rats. All animals survived the scheduled observation period. Salivation was observed during exposure in all animals. Decreased activity, hunched posture, bradypnea, ruffled fur and salivation were recorded in all animals after exposure. There were no clinical signs from day 3 onwards. There were no effects on body weight that were considered to be related to treatment with the test item. There were no macroscopic findings in any animal.
In conclusion, the LC50 of di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide obtained in this study was estimated to be greater than 5.6 mg/L air (chemically determined mean aerosol concentration). There was no indication of relevant sex-related differences in toxicity of the test item.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.